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Angelman syndrome (AS) is a neurodevelopmental
disorder caused by loss of the maternally inherited
allele of UBE3A. AS model mice, which carry
a maternal Ube3a null mutation (Ube3am/p+), reca-
pitulate major features of AS in humans, including
enhanced seizure susceptibility. Excitatory neuro-
transmission onto neocortical pyramidal neurons is
diminished in Ube3am/p+ mice, seemingly at odds
with enhanced seizure susceptibility. We show here
that inhibitory drive onto neocortical pyramidal
neurons is more severely decreased in Ube3am/p+
mice. This inhibitory deficit follows the loss of excit-
atory inputs and appears to arise from defective
presynaptic vesicle cycling in multiple interneuron
populations. In contrast, excitatory and inhibitory
synaptic inputs onto inhibitory interneurons are
largely normal. Our results indicate that there are
neuron type-specific synaptic deficits in Ube3am/p+
mice despite the presence of Ube3a in all neurons.
These deficits result in excitatory/inhibitory imbal-
ance at cellular and circuit levels and may contribute
to seizure susceptibility in AS.INTRODUCTION
Angelman syndrome (AS) is characterized by severe intellectual
disabilities, EEG abnormalities, gait disturbances, disrupted
sleep patterns, profound language impairment, and autism
(Williams et al., 2006). Seizures are present in 90% of AS
patients, significantly impacting their quality of life and that of
their caregivers (Thibert et al., 2009). AS is caused by deletions
or loss-of-function mutations in the maternally inherited allele
of UBE3A (Rougeulle et al., 1997). UBE3A encodes an E3 ubiq-
uitin ligase that, in the brain, is expressed primarily from the
maternal allele as a result of neuron-specific imprinting (Albrechtet al., 1997). Similar to humans with AS, mice lacking maternal
Ube3a (Ube3am/p+) have abnormal EEG activity and are
susceptible to cortical seizures, suggesting that loss of Ube3a
might disrupt the excitatory/inhibitory balance in the neocortex
(Jiang et al., 1998).
Loss of maternally inherited Ube3a results in decreased excit-
atory synaptic drive onto pyramidal neurons in layer 2/3 (L2/3) of
neocortex, as evidenced by a loss of dendritic spines (Yashiro
et al., 2009). Decreased Ube3a-mediated proteasomal degrada-
tion of Arc and Ephexin5 proteinsmay lead to excitatory synaptic
defects (Greer et al., 2010; Margolis et al., 2010). These observa-
tions suggest a mechanism for how the loss of Ube3amay cause
fewer and/or weaker excitatory synapses. While these deficits
may be relevant to cognitive phenotypes in Ube3am/p+ mice,
they would not on their own predict hyperexcitability and
increased seizure susceptibility. We hypothesized that Ube3a
loss results in more severe inhibitory deficits, with the net
outcome favoring cortical hyperexcitability.
Here, we use the visual cortex as a model to study the role of
Ube3a in the establishment and function of inhibitory circuits. We
show that Ube3am/p+ mice have an abnormal accumulation of
clathrin-coated vesicles at inhibitory axon terminals, indicating
a defect in vesicle cycling. Consistent with this observation,
inhibitory synaptic transmission onto L2/3 pyramidal neurons
recovers slower following vesicle depletion in Ube3am/p+
mice, compared to wild-types. Recovery following high-
frequency stimulation of excitatory synapses onto L2/3 pyra-
midal neurons, however, is normal. This discrepancy among
synapse types may further contribute to excitatory/inhibitory
imbalance during high levels of activity. Finally, we show that
synaptic inputs onto inhibitory neurons in Ube3am/p+ mice are
largely normal. We conclude that neuron type-specific synaptic
deficits are likely to underlie neocortical excitatory/inhibitory
imbalance in AS.
RESULTS
Inhibitory Deficits in Mature Ube3am–/p+ Mice
An excitatory/inhibitory imbalance in AS could arise from
reduced numbers of inhibitory interneurons, abnormal inhibitoryNeuron 74, 793–800, June 7, 2012 ª2012 Elsevier Inc. 793
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Figure 1. Inhibitory Synaptic Deficits Arising through Development
in Ube3am–/p+ Mice Are Not Due to Decreased Density of Inhibitory
Interneurons
(A) Photomicrographs showing immunocytochemical markers for inhibitory
interneurons in visual cortex of wild-type (WT) and Ube3a-deficient (m/p+)
mice. (B) Quantification of parvalbumin-, calretinin-, and somatostatin-positive
neurons in L2/3 of mouse primary visual cortex atP80 (n = 4 mice/genotype).
(C) Sample mIPSC recordings from P25 (P21–P28) and P80 (P70–P90) WT
andUbe3am/p+mice. Scale bar represents 30 pA, 400ms. (D) AveragemIPSC
amplitude was similar between WT and Ube3am/p+mice at P25 (WT n = 10
cells; m/p+ n = 8 cells) and P80 (n = 13 cells/genotype) in L2/3 pyramidal
cells. (E) Average mIPSC frequency for P25 (WT n = 10 cells; m/p+ n = 8
cells) and P80 (n = 13 cells/genotype). See also Table S1. (F) Illustration of
stimulation (L4) and recording (L2/3 pyramidal neuron) configuration in primary
visual cortex, and sample recordings of evoked IPSCs at stimulation intensities
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794 Neuron 74, 793–800, June 7, 2012 ª2012 Elsevier Inc.connectivity, and/or decreased inhibitory neurotransmission. To
test the first possibility, we performed immunohistochemistry for
three markers—parvalbumin, calretinin, and somatostatin—
which together label 96% of the total GABAergic interneurons
in L2/3 of mouse primary visual cortex (V1) (Gonchar et al.,
2007). We compared Ube3am/p+ mice and their wild-type
(WT) 129Sv/Ev strain littermate controls at postnatal day 80
(P80), an age where AS model mice exhibit abnormal EEG
patterns and are susceptible to seizures (Jiang et al., 1998).
We found no differences in the density of inhibitory interneurons
expressing these markers (Figures 1A and 1B), implying that the
relative number of inhibitory interneurons is normal in L2/3 of V1.
Next we investigated the strength and number of inhibitory
synapses onto L2/3 pyramidal neurons. Using whole-cell
voltage-clamp, we recorded miniature inhibitory postsynaptic
currents (mIPSCs) in the presence of tetrodotoxin to gauge
spontaneous inhibitory synaptic activity onto excitatory L2/3
pyramidal neurons. We recorded mIPSCs at two ages: P25,
during the critical period for ocular dominance plasticity and
when excitatory deficits have been observed previously, and
P80, when the visual cortex is fully mature. We observed no
difference in mIPSC amplitude between WT and Ube3am/p+
mice at either P25 or P80, suggesting that the loss of Ube3a
did not change the strength of inhibitory synapses (Figure 1D
and Table S1 available online). While we saw no genotypic differ-
ences in mIPSC frequency at P25, L2/3 pyramidal neurons in
Ube3am/p+ mice had a reduction in mIPSC frequency by P80
(Figure 1E). These observations indicate that the loss of Ube3a
leads to fewer functional inhibitory synapses, or a reduction of
their release probability onto L2/3 pyramidal neurons.
To further investigate the development of inhibitory inputs onto
L2/3 pyramidal neurons, we recorded evoked inhibitory postsyn-
aptic currents (eIPSCs) using L4 stimulation at different intensi-
ties in P25 and P80 Ube3am/p+ and WT mice (Figure 1F). This
type of stimulation activates diverse inhibitory inputs and, with
strong stimulation, can activate most of the inhibitory inputs
onto L2/3 pyramidal neurons (Morales et al., 2002). We saw no
significant difference in eIPSC amplitude at P25 (Figure 1G),
but a large decrease in eIPSC amplitude at P80 in Ube3am/p+
mice compared to WT (Figure 1H). Together, these results
confirm that there is a severe deficit in the amount of inhibition
arriving onto L2/3 pyramidal cells in the mature visual cortex of
Ube3am/p+ mice.
In principle, a decrease in eIPSC amplitude could arise from
reductions in the number of postsynaptic GABA receptors,
a decrease in the release probability of inhibitory axon terminals,
fewer functional inhibitory synapses, or a depolarized inhibitory
interneuron action potential threshold. It is unlikely that the
decrease in eIPSC amplitude at P80 is due to a decrease in
the number of GABA receptors at active synapses, since theof 0, 10, 30, and 100 mA. Scale bar represents 500 pA, 30ms. (G and H) Evoked
IPSCs at P25 (WT n = 26 cells; m/p+ n = 29 cells) (G) and P80 (WT n = 20
cells; m/p+ n = 14 cells) (H). (I) Sample recordings of evoked IPSCs in paired-
pulse experiments (scale bar represents 100 pA, 20 ms) and quantification of
paired-pulse ratio in mice agedP25 (WT n = 12 cells; m/p+ n = 11 cells) and
P80 (WT n = 13 cells; m/p+ n = 8 cells). All data are represented as the
mean ± SEM; **p < 0.01, ***p < 0.001. See also Figure S1.
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Figure 2. Ube3a Loss Leads to Neuron Type-Specific Defects in
Inhibitory Neurotransmission
(A1) Illustration and photomicrograph of a filled L2/3 pyramidal neuron and
sample recordings from P80 WT (upper) and Ube3am/p+ (lower) mice.
Scale bar represents 40 pA, 300 ms. (A2 and A3) Average mIPSC amplitude
(n = 11 cells/genotype, p = 0.16) (A2) and frequency (n = 11 cells/genotype)
from L2/3 pyramidal neurons (A3). (B1) Illustration and fill of a L2/3 pyramidal
neuron and sample recordings from P80 WT (upper) and Ube3am/p+ (lower)
mice. Scale bar represents 15 pA, 300 ms. (B2) Average mEPSC amplitude
(WT n = 6 cells; m/p+ n = 9 cells) and (B3) frequency (WT n = 6 cells; m/p+
n = 9 cells) from L2/3 pyramidal neurons. (C1) Illustration and fill of a L2/3 FS
inhibitory interneuron and sample recordings from P80 WT (upper) and
Ube3am/p+ (lower) mice. Scale bar represents 40 pA, 300 ms. (C2 and C3)
Average mIPSC amplitude (WT n = 13 cells; m/p+ n = 10 cells) (C2) and
frequency (WT n = 13 cells; m/p+ n = 10 cells; p = 0.57) (C3) from L2/3 FS
inhibitory interneurons. (D1) Illustration and fill of a L2/3 FS inhibitory inter-
neuron and sample recordings from P80 WT (upper) and Ube3am/p+ (lower)
mice. Scale bar represents 10 pA, 300 ms. (D2 and D3) Average mEPSC
amplitude (WT n = 13 cells; m/p+ n = 12 cells) (D2) and frequency (WT n = 13
cells; m/p+ n = 12 cells) (D3) from L2/3 FS inhibitory interneurons. Bar
graphs represent the mean ± SEM; p* < 0.05, p*** < 0.001. See also Figure S2
and Table S2.
Neuron
Neuron-Specific Defects in Angelman Syndrome Miceamplitude of mIPSCs was similar in Ube3am/p+ and WT mice.
To assess whether the decrease in eIPSC amplitude is due to
the loss of functional synapses or to a decrease in release prob-
ability, we examined the paired-pulse ratio of inhibitory inputs.Specifically, we stimulated L4 at varying interpulse intervals to
evoke IPSCs in L2/3 pyramidal cells, and compared the
paired-pulse ratio in WT and Ube3am/p+ mice. We observed
no difference in the paired-pulse ratio between genotypes at
either P25 or P80, implying that release at functional inhibitory
inputs onto L2/3 pyramidal cells is normal in response to brief
stimuli given at several interpulse intervals (Figure 1I). Finally,
we found no difference in the action potential threshold or
intrinsic excitability of FS neurons (a major class of inhibitory
interneurons) in Ube3am/p+ mice compared to WT, indicating
that reduced eIPSC amplitude is unlikely to be due to reductions
in evoked action potentials in inhibitory interneurons (Figures
S1A and S1B). By exclusion, our data suggest a reduction in
the total number of functional inhibitory synapses.
Neuron Type-Specific Reduction in Functional Synapses
in Ube3am–/p+ Mice
Our previous observations of reduced inhibition were made in
Ube3am/p+ mice on the 129Sv/Ev strain, which are susceptible
to spontaneous seizures (Jiang et al., 1998), making it difficult to
determine whether the synaptic abnormalities were a cause or
result of seizures (Sloviter, 1987). To address this concern, we
tested for possible synaptic deficits in Ube3am/p+ mice main-
tained on the C57BL/6J strain, which have a low incidence of
evoked seizures and no reported spontaneous seizures (Jiang
et al., 1998). We performed mIPSC recordings at P80 in WT
and Ube3am/p+ C57BL/6J mice to test if synaptic defects arose
in the absence of spontaneous seizures. As before, we observed
no genotypic differences in the amplitude of mIPSCs, but a large
decrease in mIPSC frequency in Ube3am/p+ mice (Figure 2A).
We also performed mEPSC recordings in L2/3 pyramidal
neurons in mice on the C57BL/6J strain to confirm previous
results from the 129Sv/Ev strain (Yashiro et al., 2009). Consistent
with previous results, there was a significant decrease in mEPSC
frequency, but not amplitude, between Ube3am/p+ and WT
mice (Figure 2B). These observations reveal that Ube3am/p+
L2/3 pyramidal neurons have a 50% reduction in spontaneous
inhibitory synaptic activity, but only a 28%decrease in excitatory
synaptic activity. Additionally, intrinsic excitability of L2/3 pyra-
midal neurons was increased in Ube3am/p+ mice compared to
WT (Figure S1C). Together these data suggest that a dispropor-
tionate loss of inhibition may lead to an excitatory/inhibitory
imbalance in Ube3am/p+ L2/3 pyramidal neurons.
Ube3a is expressed by both excitatory and inhibitory interneu-
rons in the cerebral cortex (Sato and Stryker, 2010). Therefore,
Ube3a loss might be expected to affect both neuron classes.
To assess this possibility, we recorded spontaneous synaptic
activity in fast-spiking (FS) inhibitory interneurons, which we
identified by membrane properties, aspinous dendrites, and
characteristic high firing rates (Okaty et al., 2009). FS inhibitory
interneurons in L2/3 were targeted for whole-cell recording
at P80, an age at which excitatory and inhibitory neurotrans-
mission onto L2/3 pyramidal neurons is altered. In contrast to
L2/3 pyramidal neurons, the loss of Ube3a did not affect either
the amplitude or the frequency of mIPSCs onto FS inhibitory
interneurons (Figure 2C). Moreover, excitatory connections
onto FS inhibitory interneurons appeared normal, as Ube3a
loss did not alter mEPSC amplitude or frequency (Figure 2D).Neuron 74, 793–800, June 7, 2012 ª2012 Elsevier Inc. 795
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Figure 3. Synaptic Deficits Arise from Both FS and
Non-FS Inhibitory Interneurons in Ube3am–/p+Mice
(A) Recording configuration (upper) and representative
recordings of presynaptic action potentials evoked in a FS
inhibitory interneuron (middle), and resulting unitary IPSPs
in a L2/3 pyramidal neuron (lower) from WT (blue) and
Ube3am/p+ mice (red). Average is of 12 trials. Scale bar
represents 20mV (‘‘Pre’’), 40 ms; 4mV (‘‘Post’’), 40 ms. (B)
Average short-term plasticity of inhibitory to excitatory
connections (WT n = 8; m/p+ n = 12) (presynaptic spikes
at 30 Hz). (C) Average unitary IPSP amplitude of 1st IPSP of
inhibitory to excitatory connections (WT n = 8; m/p+ n =
12). (D and E) Connection probability of FS inhibitory
interneurons to L2/3 pyramidal neurons (numbers of con-
nected/total pairs written in bars) (D); inhibitory drive of FS
inhibitory interneurons to L2/3 pyramidal neurons (WT n =
19 pairs; m/p+ n = 30 pairs) (E). (F) Recording configu-
ration (upper) and representative recordings (lower) of
eIPSCs during baseline (black) and 20 min after 500 nM
u-agatoxin-IVa perfusion (green). Scale bar represents
100 pA, 20 ms. (G) A 10 min baseline was recorded
before a 10 min perfusion of agatoxin (green bar) (WT n =
10; m/p+ n = 10). (H) Input-output relationship in the
agatoxin-insensitive portion of total eIPSC performed
20 min after cessation of agatoxin perfusion (WT n = 10;
m/p+ n = 10). Data are represented as the mean ± SEM;
*p < 0.05, **p < 0.01, ***p < 0.001. See also Figure S3 and
Table S3.
Neuron
Neuron-Specific Defects in Angelman Syndrome MiceSimilar to L2/3, Ube3a loss did not change the frequency or
amplitude of mIPSCs or mEPSCs onto L5/6 FS inhibitory inter-
neurons (Figures S2A and S2B). These results imply that
Ube3a loss has neuron type-specific synaptic effects.
Ube3a Loss Results in Inhibitory Deficits
from FS Interneurons
We examined the effects of Ube3a loss on FS inhibitory interneu-
rons, which provide themajority of perisomatic inhibitory input to
L2/3 pyramidal neurons (Jiang et al., 2010), impart feed-forward
and feedback inhibition, and have been implicated in seizure
susceptibility (Di Cristo et al., 2004). Despite the challenge of
performing paired recordings in adult neocortical slices, we
were able to investigate synaptic connectivity between 83 pairs
of L2/3 FS inhibitory interneurons and L2/3 pyramidal neurons in
WT and Ube3am/p+ mice at P80 (Table S3).
We first analyzed synaptic connectivity from FS inhibitory
interneurons to pyramidal neurons. Using current-clamp record-
ings, we evoked action potentials in FS interneurons with depo-
larizing current injections at 30 Hz, and simultaneously recorded
the response in pyramidal neurons (Figure 3A). To measure
short-term plasticity we normalized the amplitude of the evoked
IPSPs to the amplitude of the first IPSP in the train. We observed
no change in the short-term plasticity between genotypes
(Figure 3B). However, the amplitude of the first IPSP between
these pairs was significantly decreased in Ube3am/p+ mice,
indicating decreased connection strength from FS inhibitory
interneurons to L2/3 pyramidal neurons (Figure 3C). We also
found a 31% decrease in connection probability in Ube3am/p+
mice compared to WT mice (Figure 3D), supporting the con-
clusion that the decreased IPSP amplitude is likely due to
a reduction in the number of functional synapses made from796 Neuron 74, 793–800, June 7, 2012 ª2012 Elsevier Inc.FS interneurons to pyramidal neurons. Finally, we estimated
the average inhibitory drive from FS inhibitory interneurons
onto L2/3 pyramidal neurons, by calculating the product of
connection strength and connection probability, finding that
inhibitory drive was reduced by 71% in Ube3am/p+ mice
compared to WT mice (Figure 3E).
To further investigate possible effects of Ube3a loss on
synaptic connectivity, we examined the connections from L2/3
pyramidal neurons to FS inhibitory interneurons. We measured
short-term plasticity and found that Ube3am/p+ mice had
increased facilitation at synapses from pyramidal neuron to FS
interneurons (Figure S3B). To assess connection strength in
this pathway, we measured the amplitude of the first EPSP
evoked in the postsynaptic FS interneuron, detecting no differ-
ence between genotypes (Figure S3C). Finally, we found no
genotypic difference in the connection probability of L2/3 pyra-
midal to FS inhibitory interneuron pairs (Figure S3D).
These data suggest that, while excitatory connection fre-
quency and strength onto L2/3 FS interneurons are unchanged
in Ube3am/p+ mice, excitatory inputs onto FS inhibitory inter-
neurons have altered short-term plasticity, potentially leading
to defective engagement of FS inhibitory interneurons during
trains of activity. The unchanged strength of the pyramidal-to-
FS inhibitory interneuron connections in Ube3am/p+ mice
was unexpected, since short-term plasticity measurements
indicated a change in release probability at this synapse. We
conclude that other factors, such as differences in calcium buff-
ering, coupling of calcium channels to release machinery, or
vesicular trafficking, must underlie the observed changes
(Atwood and Karunanithi, 2002). Together, these experiments
identify a specific inhibitory interneuron subtype, FS inhibitory
interneurons, that is at least partially responsible for the
Neuron
Neuron-Specific Defects in Angelman Syndrome Micedecrease in inhibition found in L2/3 pyramidal neurons in the
AS model.
Ube3a Loss Results in Inhibitory Deficits
from Non-FS Interneurons
L2/3 pyramidal neurons receive inhibition from a variety of
inhibitory interneuron subtypes (Markram et al., 2004). To test
whether inhibitory deficits in Ube3am/p+ mice could also be
ascribed to other types of interneurons, we used agatoxin,
a potent irreversible antagonist of P/Q-type voltage-gated
calcium channels (VGCCs), to block release of GABA selectively
from FS inhibitory interneurons (Jiang et al., 2010). Agatoxin sup-
pressed 90% of the total eIPSCs in both WT and Ube3am/p+
mice 20 min after perfusion of the toxin (Figure 3G). The aga-
toxin-insensitive portion of the eIPSC had an increased latency
from stimulation onset and an increased rise time, suggesting
that the agatoxin-insensitive inputs targeted the distal dendrites
of L2/3 pyramidal neurons (Figures S3G and S3H). Agatoxin-
insensitive inputs also had decreased paired-pulse depression
compared to the total eIPSC, a signature of non-FS inhibitory
interneurons (Figure S3F) (Gupta et al., 2000). After agatoxin
perfusion, we recorded eIPSCs at different stimulation intensities
and again found a decrease in the strength of inhibitory inputs in
the Ube3am/p+ mice, compared to WT, demonstrating that
Ube3a loss also affects inputs from non-FS classes of inhibitory
interneurons (Figure 3H).
Ube3am–/p+ Mice Have Defects in Synaptic
Vesicle Cycling
Our electrophysiological data suggest that inhibitory deficits in
Ube3am/p+ mice result from a loss of functional inhibitory
synapses onto L2/3 pyramidal neurons. However, a reduction
in functional synapses could arise anatomically from fewer
synaptic contacts, postsynaptically by a loss of functional recep-
tors, or presynaptically by a severe depletion of releasable
synaptic vesicles rendering a subset of inhibitory axon terminals
nonfunctional. To test for an anatomical correlate to our func-
tional data, we used immunohistochemistry to stain WT and
Ube3am/p+ mice for the vesicular GABA transporter (VGAT),
a marker for the axon terminals of inhibitory interneurons
(Chaudhry et al., 1998). We were surprised to see similar densi-
ties of VGAT-positive puncta in WT and Ube3am/p+ mice, sug-
gesting no change in the number of inhibitory interneuron axon
terminals (Figures S4A–S4C). However, there remained the
possibility that some of these axon terminals were nonfunctional.
To explore this possibility, we used electron microscopy to
examine synaptic structure in WT and Ube3am/p+ mice. Post-
embedding immunogold localization of GABA was used to iden-
tify inhibitory synapses onto somata in L2/3 of V1. The area of
GABA-positive axon terminals and proportion of mitochondria
per terminal were not different between WT and Ube3am/p+
mice (Figures 4A2 and 4A3). However, there was a decrease in
the number of synaptic vesicles, and a large increase in the
number of clathrin-coated vesicles (CCVs), in the Ube3am/p+
mice compared to WT (Figures 4A4 and 4A5 and S4F and
S4G). We also tested whether the defects we observed in
inhibitory synapses were generalized to excitatory synapses.
Similar to inhibitory synapses, we observed a decrease in thenumber of synaptic vesicles, but no change in the area of excit-
atory axon terminals or the proportion of mitochondria per
terminal (Figures 4B1–4B4 and S4D and S4E). Finally, we saw
little or no decrease in the number of CCVs at excitatory
synapses between genotypes (Figures 4B5 and S4D and S4E).
These data suggest a defect in synaptic vesicle cycling in inhib-
itory synapses of Ube3am/p+ mice.
Incomplete Recovery of IPSCs after High-Frequency
Stimulation in Ube3am–/p+ Mice
Previous studies examining synaptic vesicle cycling have identi-
fied genes whose mutation leads to increased numbers of CCVs
in axon terminals (Slepnev and De Camilli, 2000). Many of these
mutant synapses maintain the ability to release neurotransmitter
and have normal short-term plasticity; however, during periods
of high activity these synapses fail to adequately replenish their
synaptic vesicle pool, resulting in a delayed recovery to baseline
levels of transmitter release (Luthi et al., 2001). These studies led
us to test whether inhibitory synapses in the Ube3am/p+ mice
had functional deficits similar to other synaptic vesicle cycling
mutants. We applied a train of 800 stimuli at 10 Hz while
recording eIPSCs in L2/3 pyramidal neurons in WT and
Ube3am/p+mice (Figure 4C).We then decreased the stimulation
frequency to 0.33 Hz and recorded the recovery phase of the
eIPSC (Figure 4C1). Ube3a loss had no effect on the depletion
phase of the eIPSC (Figure 2C2) in agreement with our previous
experiments examining short-term plasticity (Figures 1I and 3B).
However, we found a large decrease in the rate and level of
recovery of the eIPSC inUbe3am/p+mice compared toWT (Fig-
ure 4C3). These data are consistent with defects in inhibitory
synaptic vesicle cycling in Ube3am/p+ mice. Specifically, the
decrease in recovery of the eIPSC, combined with the increase
in CCVs, suggests an inability of newly endocytosed CCVs to
reenter and replenish the synaptic vesicle pool. These defects
may render a subset of inhibitory synapses nonfunctional in
Ube3am/p+ mice.
Finally, we challenged excitatory synapses with the same high
frequency stimulation protocol that we used to test inhibitory
synapses (Figure 4D1). Unlike inhibitory synapses, Ube3a loss
did not have an effect on the recovery of excitatory synapses
from high-frequency stimulation (Figure 4D3). Thus, the
pronounced accumulation of CCVs observed at inhibitory
synapses correlates well with the selective deficits in the
synaptic recovery from high-frequency stimulation. Moreover,
these functional data demonstrate that a period of heightened
excitatory/inhibitory imbalance may occur following a high-
frequency train of activity in this circuit.
DISCUSSION
This work demonstrates that maternal loss of Ube3a, as seen in
individuals with AS, leads to neuron type-specific synaptic defi-
cits. Our findings suggest that loss of Ube3a can result in an
excitatory/inhibitory imbalance in the neocortex.
Earlier studies showing decreased excitatory neurotransmis-
sion in Ube3am/p+ mice were difficult to reconcile with reports
of high seizure susceptibility (Jiang et al., 1998; Yashiro et al.,
2009). Our data provides clarification, showing that the loss ofNeuron 74, 793–800, June 7, 2012 ª2012 Elsevier Inc. 797
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Figure 4. Inhibitory Synapses of Ube3am–/p+ Mice Have Presynaptic Defects
(A1) Electron micrographs of inhibitory synapses stained for GABA in P80 WT and Ube3am/p+ mice (green denotes axon terminal, blue denotes soma),
insets highlight CCVs. Scale bar represents 250 nm. Average values of (left to right) (A2) axon terminal area, (A3) mitochondrial area divided by terminal area, (A4)
number of synaptic vesicles per mm2, and (A5) number of CCVs per mm
2 (WT n = 3; m/p+ n = 4). (B1) Electron micrographs of excitatory synapses in WT and
Ube3am/p+ mice (green denotes axon terminal, red denotes spine). Scale bar represents 250 nm. Average values of (left to right) (B2) axon terminal area, (B3)
mitochondrial area divided by terminal area, (B4) number of synaptic vesicles per mm
2, and (B5) number of CCVs per mm
2 (WT n = 3; m/p+ n = 4). (C1) Sample
recordings (left) and sample experiment (right) showing baseline (black), high frequency depletion (orange), and recovery (black) phases. Scale bars represent
baseline = 200 pA, 20 ms; depletion = 200 pA, 200 ms; recovery = 200 pA, 20 ms. (C2) Average depletion phase showing eIPSC amplitude normalized to baseline
during 800 stimuli at 10 Hz. Ten responses are averaged for each point and a monophasic exponential was fit to the averaged responses for WT and Ube3am/p+
mice (WT n = 19; m/p+ n = 18). (C3) Average recovery phase showing eIPSC amplitude normalized to baseline during 90 stimuli at 0.33 Hz. Three responses are
averaged for each point and a monophasic exponential was fit to the averaged responses for WT and Ube3am/p+mice (WT n = 19; m/p+ n = 18). (D1) Sample
recordings (left) and sample experiment (right) showing baseline (black), high frequency depletion (orange), and recovery (black) phases. Scale bars represent
baseline = 100 pA, 10ms; depletion = 100 pA, 200ms; recovery = 100 pA, 10ms. (D2) Average depletion phase showing eEPSC amplitude normalized to baseline
during 800 stimuli at 10 Hz. Ten responses are averaged for each point and a monophasic exponential was fit to the averaged responses for WT and Ube3am/p+
mice (WT n = 10; m/p+ n = 11). (D3) Average recovery phase showing eEPSC amplitude normalized to baseline during 90 stimuli at 0.33 Hz. Three responses are
averaged for each point and a monophasic exponential was fit to the averaged responses for WT and Ube3am/p+ mice (WT n = 10; m/p+ n = 11). Data are
represented as the mean ± SEM; *p < 0.05, ***p < 0.001.
See also Figure S4.
Neuron
Neuron-Specific Defects in Angelman Syndrome MiceUbe3a causes a particularly severe decrease in inhibitory input
to L2/3 pyramidal neurons. We also report that AS model mice
have a synaptic vesicle cycling defect, which suggests a basis
for this deficit. The vesicle cycling defects we observe are similar
to those observed after deletion of the presynaptic proteins798 Neuron 74, 793–800, June 7, 2012 ª2012 Elsevier Inc.synaptojanin (Cremona et al., 1999) or endophilin (Milosevic
et al., 2011), both which lead to increased CCVs at synaptic
terminals, and decreased synaptic recovery from high levels of
activity. Notably, inhibitory synapses may be particularly sensi-
tive to disruptions in vesicular trafficking, due to their enhanced
Neuron
Neuron-Specific Defects in Angelman Syndrome Miceactivity and smaller vesicle pools (Hayashi et al., 2008). These
results, combined with our functional studies describing defec-
tive inhibitory synaptic transmission in Ube3am/p+ mice,
suggest a means by which a hyperexcitable cortical circuit could
arise despite fewer excitatory synapses.
Ube3a is present in both excitatory and inhibitory interneurons
in the brain (Sato and Stryker, 2010). Our results showing
different synaptic defects onto excitatory and inhibitory neurons
indicate Ube3a deficiency causes neuron type-specific deficits.
Since Ube3a targets its substrate proteins for proteasomal
degradation, the consequences of Ube3a loss may depend on
which substrate proteins are normally present in a cell. This
hypothesis is supported by recent work showing that Arc,
a protein expressed postsynaptically in excitatory but not
inhibitory interneurons, is a Ube3a substrate (Greer et al.,
2010; McCurry et al., 2010). Thus, the loss of Ube3a is expected
to cause an inappropriate overexpression of Arc in excitatory
neurons without affecting inhibitory interneurons. Given the
ability of Arc to influence AMPA receptor endocytosis (Chowd-
hury et al., 2006), the neuron type-specific expression of Arc
could partly explain the excitatory synaptic defects observed
onto L2/3 pyramidal neurons and the lack of effect in FS inter-
neurons. Conversely, our findings suggest a synaptic defect in
Ube3am/p+ mice at inhibitory synapses, primarily affecting
presynaptic function at inhibitory synapses and resulting in fewer
functional synapses. Intriguingly, the observed excitatory and
inhibitory defects both involve endocytic processes, albeit at
different sides of the synaptic cleft, suggesting that common
processes may be involved.
Altered function of GABA receptors and/or inhibitory interneu-
rons has been hypothesized to underlie many of the phenotypes
seen in AS (Dan and Boyd, 2003). While attention has focused on
how defects in GABAergic neurotransmission may relate to
epileptic phenotypes in AS, abnormalities in inhibition can have
wide-ranging consequences, including disrupting synaptic
plasticity, cortical network oscillations, and cortical circuit
architecture (Cardin et al., 2009; Hensch, 2005). For example,
FS inhibitory interneurons have a critical role in ocular domi-
nance plasticity (Hensch et al., 1998), which is severely reduced
in Ube3am/p+ mice (Sato and Stryker, 2010; Yashiro et al.,
2009). Our finding that inhibitory interneuron to L2/3 pyramidal
neuron connections are altered in Ube3am/p+ mice may prove
important for understanding the mechanisms underlying plas-
ticity and learning defects in AS. Understanding the specific
synaptic impairments caused by the global loss of Ube3a may
provide insights into the intractable nature of seizures found in
many individuals with AS.
Excitatory/inhibitory imbalance has been observed in several
genetic disorders that meet diagnostic criteria for autism
spectrum disorders, including neuroligin-3 mutation, Fragile X,
and Rett syndrome (Dani et al., 2005; Gibson et al., 2008; Tab-
uchi et al., 2007). Moreover, excitatory/inhibitory imbalance
may be a general neurophysiological feature of autism spec-
trum disorders, contributing to inappropriate detection or inte-
gration of salient sensory information due to a decreased
signal-to-noise ratio (Rubenstein and Merzenich, 2003). Our
finding that an excitatory/inhibitory imbalance may develop in
AS due to the loss of functional inhibitory synapses highlightsthe importance of identifying Ube3a substrates in inhibitory
interneurons.
EXPERIMENTAL PROCEDURES
See Supplemental Experimental Procedures for details relating to electrophys-
iology and immunohistochemistry.
Animals
Ube3a-deficient mice on the 129Sv/Ev background were originally developed
by Jiang et al. (1998) and obtained through the Jackson Laboratory (Bar
Harbor, ME). Ube3a-deficient mice backcrossed onto the C57BL/6J back-
ground were obtained from Yong-hui Jiang (Duke University) and crossed
with mice expressing GFP in a subset of FS inhibitory neurons (Chattopad-
hyaya et al., 2004) obtained through Jackson Laboratory. All studies were
conducted with protocols approved by the University of North Carolina at
Chapel Hill Animal Care and Use Committee.
Statistics
Most experiments and analyses were performed blind to genotype. Unpaired
Students t tests were used on all data excluding the following; input-output,
frequency-current, short-term plasticity, connection probability, and for
depletion and recovery experiments. Graphs represent the mean and error
bars represent the SEM. For all figures p-values are as follows *p < 0.05,
**p < 0.01, ***p < 0.001. All statistics were performed in Graphpad Prism.
SUPPLEMENTAL INFORMATION
Supplemental Information includes four figures, three tables, and Supple-
mental Experimental Procedures and can be found with this article online at
doi:10.1016/j.neuron.2012.03.036.
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